Healthcare Blogs and Articles

Influenza Vaccine Effectiveness Lower In Recent Months, Preliminary Data Show
BlogMar 14, 2026

Influenza Vaccine Effectiveness Lower In Recent Months, Preliminary Data Show

Preliminary CDC data show influenza vaccine effectiveness fell sharply in the 2025‑2026 season, ranging from 14‑48% in children and 22‑34% in adults. The decline follows the agency’s January decision to stop recommending universal flu shots for all children. Experts cite...

By ZeroHedge – Markets
First-Generation Physician: Navigating the First Attending Contract
BlogMar 14, 2026

First-Generation Physician: Navigating the First Attending Contract

First‑generation physicians often face an opaque transition from residency to their first attending contract, lacking inherited mentorship and clear career roadmaps. Sagar Chapagain shares personal experience and offers five practical strategies—clarifying values, strategic mentorship, long‑term thinking, reputation building, and trusting...

By KevinMD
The Myth of “Brain-Safe” Vaginal Progesterone
BlogMar 14, 2026

The Myth of “Brain-Safe” Vaginal Progesterone

A viral claim suggests oral progesterone harms brain health while vaginal progesterone is safer for menopausal hormone therapy. The author refutes this by citing the KEEPS trial, which showed no cognitive decline or MRI changes after four years of oral...

By The Vajenda
EXCLUSIVE: HOLLYWOOD FACING OZEMPIC SHORTAGE AS OSCARS FUEL CELEBRITY STOCKPILING
BlogMar 14, 2026

EXCLUSIVE: HOLLYWOOD FACING OZEMPIC SHORTAGE AS OSCARS FUEL CELEBRITY STOCKPILING

Hollywood is experiencing a sudden shortage of the weight‑loss drug Ozempic as the Academy Awards approach, with celebrities and their assistants scouring New York, Mexico and beyond to secure injections. The surge in demand is prompting a shift in typical...

By ROB SHUTER'S Naughty But Nice
BREAKING: Tennessee Bill Would Ban Administration Of mRNA Vaccines In Humans And Animals
BlogMar 14, 2026

BREAKING: Tennessee Bill Would Ban Administration Of mRNA Vaccines In Humans And Animals

Tennessee lawmakers introduced Senate Bill 1767 and its House counterpart HB1852 to prohibit the administration of any mRNA‑based vaccine or injectable to both humans and animals. The proposal defines mRNA vaccines broadly, including self‑amplifying formats, and classifies violations as Class A...

By Exposing The Darkness
Lowercase PTSD: Why Emergency Staff Are Still Hypervigilant
BlogMar 14, 2026

Lowercase PTSD: Why Emergency Staff Are Still Hypervigilant

Emergency department nurses recount how relentless COVID‑19 surges forced them into constant crisis mode, creating a state of hypervigilance that persists beyond the pandemic. The author coins “lowercase PTSD” to describe subtle, chronic trauma symptoms such as irritability, exhaustion, and...

By KevinMD
What Covid Policy Did to Doctors Who Refused to Stay Silent
BlogMar 14, 2026

What Covid Policy Did to Doctors Who Refused to Stay Silent

The author, a frontline ICU doctor, recounts how Covid‑19 policies silenced physicians who questioned official treatment guidelines. Hospitals, medical boards, and media labeled dissent as misinformation, leading to professional retaliation, loss of income, and personal hardship. He describes a 60%...

By QTR’s Fringe Finance
Improving Tobacco Treatment in Clinical Practice
BlogMar 14, 2026

Improving Tobacco Treatment in Clinical Practice

Dr. Edward Anselm warns that tobacco cessation remains inconsistently delivered despite being a low‑cost, high‑impact intervention for the 28 million U.S. smokers. He outlines a systematic approach: accurate EMR screening, routine quit advice, evidence‑based medication (notably varenicline), counseling, scheduled follow‑ups, and...

By KevinMD
The USB-C Port for Healthcare AI: Why MCP Is the Protocol That Actually Matters Right Now
BlogMar 14, 2026

The USB-C Port for Healthcare AI: Why MCP Is the Protocol That Actually Matters Right Now

The Model Context Protocol (MCP), open‑sourced by Anthropic and now governed by the Linux Foundation, is gaining rapid industry adoption as a universal "USB‑C" for AI‑driven healthcare applications. By flattening the M × N integration matrix, MCP lets any AI model plug...

By Thoughts on Healthcare Markets & Tech
EGFR Vs. ALK: How Molecular Profiling Defines Lung Cancer Treatment
BlogMar 14, 2026

EGFR Vs. ALK: How Molecular Profiling Defines Lung Cancer Treatment

Comprehensive molecular profiling of two stage IV NSCLC patients revealed distinct driver alterations—an EGFR exon 19 deletion in one and an EML4‑ALK fusion in the other—prompting personalized first‑line therapy with osimertinib and alectinib respectively. Both patients experienced rapid symptomatic improvement and enhanced...

By KevinMD
If You Want Doctors to Listen, Stop Talking Like This
BlogMar 14, 2026

If You Want Doctors to Listen, Stop Talking Like This

The author attended a Vaccine Policy Day event in Washington, D.C., and observed that extreme language—such as the “Massive Epidemic of Vaccine Injury” title—deters mainstream physicians from engaging. While legitimate safety concerns exist, alarmist rhetoric causes doctors to dismiss the...

By Dr. Gator - Between a Shot and Hard Place
The Lost Art of Connection: Why Medicine Needs to Slow Down
BlogMar 14, 2026

The Lost Art of Connection: Why Medicine Needs to Slow Down

Dean Robosa, MD reflects on how modern medicine has become a rushed, transactional business, leaving little time for deep doctor‑patient conversations. He notes that essential assessments like the Geriatric Depression Scale are rarely performed because clinicians are pressured to prioritize...

By KevinMD
YolTech Therapeutics Receives FDA Clearance to Initiate Phase 2/3 Study of In Vivo Gene-Editing Therapy YOLT-202 in Alpha-1 Antitrypsin Deficiency...
BlogMar 14, 2026

YolTech Therapeutics Receives FDA Clearance to Initiate Phase 2/3 Study of In Vivo Gene-Editing Therapy YOLT-202 in Alpha-1 Antitrypsin Deficiency...

YolTech Therapeutics announced FDA approval of its IND for YOLT-202, an in vivo adenine base‑editing therapy targeting Alpha‑1 Antitrypsin Deficiency. The clearance permits an open‑label, single‑dose Phase 2/3 expansion study across the U.S. and other regions. In the ongoing first‑in‑human trial,...

By HealthTech HotSpot
Advanced eClinical Training Expands Nationwide Clinical Partner Network, Strengthening Medical Assistant Workforce Pipeline
BlogMar 14, 2026

Advanced eClinical Training Expands Nationwide Clinical Partner Network, Strengthening Medical Assistant Workforce Pipeline

Advanced eClinical Training (ACT) announced that its clinical partner network now spans more than 1,000 healthcare sites across the United States, providing externship placements for students in its medical‑assistant, phlebotomy and allied‑health programs. The company’s extern‑to‑hire model lets providers evaluate...

By HealthTech HotSpot
Medicare Is About to Spend $100 Million on “Functional Medicine.”
BlogMar 14, 2026

Medicare Is About to Spend $100 Million on “Functional Medicine.”

The CMS Innovation Center has launched the MAHA ELEVATE pilot, earmarking $100 million to award grants to up to 30 organizations over three years beginning September 2026. The program aims to test whole‑person health approaches—including nutrition, exercise, sleep and stress management—and...

By Dr. Rubin's Substack
The Health Care Economic Crisis: Why the System Is Failing in 2026
BlogMar 13, 2026

The Health Care Economic Crisis: Why the System Is Failing in 2026

The United States health‑care system is now the costliest globally while delivering the poorest outcomes among industrialized nations. A 2025 study shows 35% of Americans lack affordable insurance, a figure projected to reach 40% in 2026, and patient collection rates...

By KevinMD
How Dompé Is Innovating in Neuro-Ophthalmology with the FDA’s CNPV Program
BlogMar 13, 2026

How Dompé Is Innovating in Neuro-Ophthalmology with the FDA’s CNPV Program

Dompe, a privately owned biopharma, is advancing an intranasal nerve growth factor (NGF) therapy to treat non‑arteritic anterior ischemic optic neuropathy (NAION), a leading cause of sudden vision loss affecting roughly 6,000 U.S. patients annually. The approach leverages NGF’s neuroprotective...

By Xtalks – Biotech Blogs
How to Choose the Right Medicare Coverage in Retirement
BlogMar 13, 2026

How to Choose the Right Medicare Coverage in Retirement

Turning 65 activates Medicare eligibility, but retirees face a maze of parts, plans, and supplements. The system comprises four core parts—A (hospital), B (outpatient), C (Medicare Advantage), and D (prescription drugs)—each with distinct coverage and cost structures. Beneficiaries must choose...

By Retirement Researcher
The Health Care Credentialing Gap: Why Top-Down Hiring Fails
BlogMar 13, 2026

The Health Care Credentialing Gap: Why Top-Down Hiring Fails

The health‑care sector continues to pour seven‑figure bonuses into elite physicians while neglecting the training of frontline nursing assistants, widening a credentialing gap at the base of care delivery. WHO projects an 11 million worker shortfall by 2030, underscoring that prestige...

By KevinMD
How In-Home Care Creates Peace of Mind for Families
BlogMar 13, 2026

How In-Home Care Creates Peace of Mind for Families

In‑home care services provide personalized assistance that enables seniors to remain in familiar surroundings while receiving professional support. Caregivers monitor health, manage medication, and adapt routines, which helps prevent emergencies and reduces the physical and emotional burden on families. Flexible...

By FAD Magazine
Pharmaceutical Executive Daily: FDA Expands Approval for Arexvy
BlogMar 13, 2026

Pharmaceutical Executive Daily: FDA Expands Approval for Arexvy

A West Health‑Gallup survey reveals that over 82 million Americans have reduced daily spending to afford healthcare, highlighting deepening affordability pressures across income levels. The FDA has broadened GSK’s RSV vaccine Arexvy to cover high‑risk adults aged 18‑49, a group responsible...

By Pharmaceutical Executive (independent trade outlet)
ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera™ Mapping and Ablation System with Sphere-9™ Catheter to Ambulatory Surgery...
BlogMar 13, 2026

ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera™ Mapping and Ablation System with Sphere-9™ Catheter to Ambulatory Surgery...

ACCESS GPO has signed a multi‑year preferred agreement with Medtronic to supply the Affera™ Mapping and Ablation System, featuring the Sphere‑9™ catheter, to physician‑led ambulatory surgery centers across the United States. The partnership aims to accelerate adoption of pulsed field...

By HealthTech HotSpot
Epic V. Health Gorilla: GuardDog Folds
BlogMar 13, 2026

Epic V. Health Gorilla: GuardDog Folds

Epic Systems secured a stipulated judgment and permanent injunction against GuardDog Telehealth in its lawsuit with Health Gorilla. GuardDog admitted its business model involved requesting and summarizing medical records via the Carequality and TEFCA interoperability frameworks under the guise of...

By Health API Guy
Ketamine Therapy for Chronic Pain and Substance Misuse
BlogMar 13, 2026

Ketamine Therapy for Chronic Pain and Substance Misuse

Recent peer‑reviewed study of 20 adults with chronic pain and substance misuse found ketamine therapy improved pain, mood, and dependence scores. The integrated treatment was delivered within a coordinated pain program, highlighting benefits of interdisciplinary care. Findings suggest ketamine can...

By KevinMD
Sami
BlogMar 13, 2026

Sami

Sami, a Brazil‑based digital health insurer, combines a proprietary platform with a network of family doctors and specialty clinics to deliver affordable primary care for small and medium‑sized enterprises. The company recently closed a R$60 million financing round aimed at scaling...

By Everywhere VC
Renal Cell Carcinoma Strategic Intelligence Report
BlogMar 13, 2026

Renal Cell Carcinoma Strategic Intelligence Report

The latest ASCO GU strategic intelligence report spotlights renal cell carcinoma (RCC) as a field entering a transformative phase. Analysts highlight emerging biomarkers, novel HIF‑2α inhibitors, and evolving immunotherapy combinations as potential high‑impact developments. While these advances promise to reshape...

By Biotech Strategy Blog
Jackson Healthcare President Shane Jackson Honored on “Staffing 100” List of Leaders Shaping the Workforce Solutions Industry
BlogMar 13, 2026

Jackson Healthcare President Shane Jackson Honored on “Staffing 100” List of Leaders Shaping the Workforce Solutions Industry

Jackson Healthcare president Shane Jackson was named to the 2026 Staffing 100 North America list, marking his ninth consecutive appearance. During his tenure, the company added a dozen acquisitions, broadened its portfolio to include executive search, allied health, nursing, surgical services...

By HealthTech HotSpot
Western Alliance Bank Launches Healthcare Industry Specialization, Led by Industry Veteran Jennifer Hwang
BlogMar 13, 2026

Western Alliance Bank Launches Healthcare Industry Specialization, Led by Industry Veteran Jennifer Hwang

Western Alliance Bank announced the launch of a dedicated Healthcare commercial banking team, headed by industry veteran Jennifer Hwang. The new unit will serve subsectors such as specialty pharmaceuticals, medical devices, home health, hospice, and ambulatory surgical centers. Leveraging the...

By HealthTech HotSpot
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
BlogMar 13, 2026

Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection

Aditxt, Inc. announced the acquisition of Ignite Proteomics for $36 million in Series A‑2 convertible preferred stock, adding a CLIA‑certified functional proteomics platform to its oncology portfolio. Ignite’s Reverse Phase Protein Array (RPPA) assay quantifies 32 phospho‑ and total‑protein biomarkers, offering therapy‑selection...

By HealthTech HotSpot
New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should Be Accessible and...
BlogMar 13, 2026

New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should Be Accessible and...

Guardant Health released a Harris Poll showing 92% of Americans aged 45+ support no‑copay coverage for blood‑based colorectal cancer (CRC) screening. The survey highlighted anxiety around colonoscopies and disgust for stool tests as major barriers, while 77% said a FDA‑approved...

By HealthTech HotSpot
3D Printing Smaller Than a Human Hair: A BMF Deep Dive with John Kawola
BlogMar 13, 2026

3D Printing Smaller Than a Human Hair: A BMF Deep Dive with John Kawola

Boston Micro Fabrication (BMF) showcased a dual‑resolution 3D printer capable of producing functional parts with tolerances in the tens of microns—smaller than a human hair. CEO John Kawola explained how the machine alternates between macro and micro modes, delivering both...

By Med-Tech Insights
How Trump’s New Global Gag Rules Will Undermine US Interests Abroad
BlogMar 13, 2026

How Trump’s New Global Gag Rules Will Undermine US Interests Abroad

The Trump administration issued three final rules that expand the Mexico City Policy to all U.S. foreign assistance, tying roughly $40 billion in non‑military aid to compliance with anti‑abortion, gender‑ideology, and DEI restrictions. The rules prohibit NGOs receiving any U.S. funds...

By Just Security
Gender and Autism Spectrum Disorder
BlogMar 13, 2026

Gender and Autism Spectrum Disorder

Recent research highlights a striking overlap between autism spectrum disorder (ASD) and gender dysphoria, with studies reporting 35‑47% of youth in gender clinics also meeting autism criteria. Sensory processing challenges and body‑image discomfort often drive autistic individuals toward clothing and...

By Inspecting Gender
Building Trust Before Scale: A Founder-to-Founder Conversation on Brand, AI and Health
BlogMar 13, 2026

Building Trust Before Scale: A Founder-to-Founder Conversation on Brand, AI and Health

Epic Life’s founder Ben Davies partnered with Koto’s James Greenfield early on to embed brand and trust before building their AI‑powered health companion. They argue that while AI functionality can be duplicated, a credible brand and identity are hard to...

By Health Tech World
ICB Mergers and Clusters: What They Mean for Continuing Healthcare
BlogMar 13, 2026

ICB Mergers and Clusters: What They Mean for Continuing Healthcare

A wave of Integrated Care Board (ICB) mergers and clustering is set to roll out across England, with many consolidations taking effect in April 2026 and further changes slated for 2027. The reforms aim to cut ICB operating and programme...

By Health Tech World
Pharma Pulse: SteinCares Partners to Expand Biosimilar Access in Latin America and Eli Lilly Issues Warning Over Compounded Tirzepatide Safety
BlogMar 13, 2026

Pharma Pulse: SteinCares Partners to Expand Biosimilar Access in Latin America and Eli Lilly Issues Warning Over Compounded Tirzepatide Safety

SteinCares and Shilpa Biologicals have signed a licensing deal to commercialize biosimilars across Latin America, with SteinCares handling regional registration and distribution while Shilpa oversees product development and long‑term manufacturing. The partnership targets broader patient access to cost‑effective biologics in...

By Pharmaceutical Commerce (independent trade)
She Tried to Build Her Own Lean Coaching AI. Then She Subscribed to Mine.
BlogMar 13, 2026

She Tried to Build Her Own Lean Coaching AI. Then She Subscribed to Mine.

A senior continuous‑improvement coach at a community hospital subscribed to the Lean Hospitals Coach after failing to build a custom AI tool. The platform combines Lean problem‑solving structure with Socratic coaching, catching errors like solution‑laden problem statements in real time....

By Lean Blog
Rethinking India’s Healthcare System: Design Is the Main Issue
BlogMar 13, 2026

Rethinking India’s Healthcare System: Design Is the Main Issue

India’s health crisis stems more from systemic design flaws than from a lack of funding. The current insurance and financing structures incentivize hospitalization, leaving primary care under‑developed and driving high out‑of‑pocket costs. Research cited by Nachiket Mor shows that, when...

By Mostly Economics
Evaluating Digital Health Tools for Chronic Disease Tracking
BlogMar 13, 2026

Evaluating Digital Health Tools for Chronic Disease Tracking

A Lancet Digital Health review of 77 studies shows objective cough monitoring outperforms traditional patient‑reported outcomes for chronic respiratory disease. Continuous, sensor‑derived cough counts provide high‑resolution, bias‑free data that can serve as a digital biomarker when combined with acoustic signatures...

By Journal of mHealth
Indian H1B Scammers Found Guilty In Multi-Million Dollar Fraud In Pennsylvania
BlogMar 13, 2026

Indian H1B Scammers Found Guilty In Multi-Million Dollar Fraud In Pennsylvania

Federal jury in Philadelphia convicted Pennsylvania brothers Bhaskar and Arun Savani and associate Aleksandra Radomiak for a decade‑long racketeering scheme that siphoned more than $32 million from the state Medicaid program. The Savani Group used sham dental practices, false H‑1B visa...

By ZeroHedge – Markets
SoundHound at HIMSS26: How MUSC Health Turned a Staffing Crisis Into a Voice AI Success Story
BlogMar 13, 2026

SoundHound at HIMSS26: How MUSC Health Turned a Staffing Crisis Into a Voice AI Success Story

SoundHound AI showcased its enterprise‑wide Amelia voice‑AI platform at HIMSS26, highlighting a massive deployment at MUSC Health. The system, branded Emily, has processed over 2.2 million calls across patient access, revenue cycle and pharmacy, automating one‑quarter of interactions and achieving a...

By HealthTech HotSpot
Heidi Arrives at HIMSS26 with R1 Partnership and a Platform Built Beyond the Scribe
BlogMar 13, 2026

Heidi Arrives at HIMSS26 with R1 Partnership and a Platform Built Beyond the Scribe

Heidi used HIMSS26 to unveil its biggest product and partnership moves since launching its ambient AI scribe, announcing a revenue‑cycle integration with R1 and a new clinical‑evidence tool called Evidence. The company says the platform now handles over 2.7 million visits...

By HealthTech HotSpot
Functionalized Nanoparticles Could Open the Door to Swallowable Insulin Pills
BlogMar 12, 2026

Functionalized Nanoparticles Could Open the Door to Swallowable Insulin Pills

Researchers have grafted the permeation enhancer 1‑phenylpiperazine onto safe silica nanoparticles, creating a hybrid that boosts intestinal insulin absorption while eliminating toxicity. In obese, insulin‑resistant mice, oral insulin delivered with these functionalized particles lowered blood glucose for 8‑10 hours, outperforming...

By Nanowerk
Heat Therapy Activates Proteins that Repair Cells and Protect the Heart [PODCAST]
BlogMar 12, 2026

Heat Therapy Activates Proteins that Repair Cells and Protect the Heart [PODCAST]

Physician‑researcher Dr. Khushali Jhaveri examined the health claims surrounding infrared saunas, noting that most data derive from Finnish‑style sauna studies. A 20‑year Finnish cohort of 2,300 men showed 22‑40% lower risks of cardiac death, coronary mortality, and all‑cause mortality with...

By KevinMD
The 9 Laws of Health Care Quality: Why Metrics Miss the Point
BlogMar 12, 2026

The 9 Laws of Health Care Quality: Why Metrics Miss the Point

Constantine Ioannou, MD, argues that health‑care quality programs have become dominated by paperwork and metrics, sidelining clinical judgment and patient narratives. He outlines nine “laws” illustrating how excessive forms, compliance‑driven interventions, and the creation of new checklists after adverse events...

By KevinMD
Closing the 9-Year Gap: A New Biomarker Targets the Diagnostic Delay in Axial Spondyloarthritis
BlogMar 12, 2026

Closing the 9-Year Gap: A New Biomarker Targets the Diagnostic Delay in Axial Spondyloarthritis

Axial spondyloarthritis affects about 1.4% of adults but patients wait an average of nine years for diagnosis in North America, far longer than rheumatoid arthritis. Augurex has introduced SPINEstat, an anti‑14‑3‑η multiplex blood test that can distinguish inflammatory back pain...

By Xtalks – Biotech Blogs
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
BlogMar 12, 2026

Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals

Senate Democrats, led by Sen. Ron Wyden, have sent letters to eleven pharmaceutical companies demanding details on their most‑favored‑nation (MFN) agreements and whether those prices generate real savings for Medicaid, with a March 23 response deadline. The inquiry follows earlier requests...

By Pharmaceutical Executive (independent trade outlet)
CT Doctors Defend Vaccine Standards During Legislative Hearing
BlogMar 12, 2026

CT Doctors Defend Vaccine Standards During Legislative Hearing

During a Connecticut Public Health Committee hearing, more than a dozen physicians testified in favor of legislation that would reaffirm the state’s ban on non‑medical vaccine exemptions. The proposal amends the 1993 Religious Freedom Restoration Act to explicitly preserve the...

By CT Capitol Dispatch
How AI in Dentistry Is Changing Your Next Checkup
BlogMar 12, 2026

How AI in Dentistry Is Changing Your Next Checkup

Artificial intelligence is already embedded in dental offices, primarily analyzing X‑rays to highlight cavities, bone loss, and other abnormalities within seconds. Predictive analytics are emerging, allowing dentists to flag patients at heightened risk for gum disease or decay before symptoms...

By KevinMD Tech